2018 American Transplant Congress
Liver Transplantation in Patients with Spontaneous Spleno-Renal Shunt
Aim: Our aim was to describe the outcomes of liver transplantation (LT) in patients with spontaneous spleno-renal shunt (SSRS) and to define the adequate portal…2018 American Transplant Congress
Intervention for Splenorenal Shunt May Decrease the Incidence of Post-Liver Transplant Acute Kidney Injury
Dept. of Surgery, University of Virginia Health System, Charlottesville, VA.
Background: Splenorenal shunt (SRS) is a type of portosystemic shunt that develops frequently in the setting of chronic portal hypertension and cirrhosis. It remains controversial…2018 American Transplant Congress
Surgical Technique and Outcomes of Portal Vein Reconstruction of Adult-to-Adult Living Donor Liver Transplantation Recipients with Portal Vein Thrombosis
Objectives: Portal vein (PV) reconstruction is a crucial factor for successful living donor liver transplantation (LDLT). Portal vein thrombosis (PVT) remains a critical problem in…2017 American Transplant Congress
Percutaneous Direct Intrahepatic Portosystemic Shunt as a Bridge to Liver Transplantation in Pediatric Patients with Variceal Bleeding.
Context: Transjugular intrahepatic portosystemic shunt (TIPS) creation is technically challenging in children due to their small size. The percutaneous direct intrahepatic portosystemic shunt (DIPS) has…2017 American Transplant Congress
Porta Systemic Shunts Helps Us to Delay or Avoid Liver Transplantation in Patients with Portal Hypertension Post Kasai Operation for Biliary Atresia.
Paediatric Surgery and Transplant Surgery, Children's Hospital at Westmead, Sydney, NSW, Australia
We present a series of 10 patients who had Kasai operation for biliary atresia in the neonatal period. These patients had optimally functioning liver in…2016 American Transplant Congress
Left Renal Vein Ligation for Management of Portal Hypoperfusion in Liver Transplantation.
Henry Ford Transplant Institute, Henry Ford Hospital, Detroit, MI.
Intro: In orthotopic liver transplant (OLT), low portal venous flow (PVF) is an independent risk factor for 1-year mortality. Ligation of existing portosystemic shunts is…2016 American Transplant Congress
Outcomes of Anticoagulation Use for Portal Vein Thrombosis in University of Wisconsin Liver Transplant Patients.
Background: The prevalence of Portal Vein Thrombosis (PVT) in cirrhotic liver transplant patients increases the risk of morbidity and mortality post-liver transplantation. Current research suggests…2016 American Transplant Congress
Hepatic Hemodynamics (HD) and Portal Flow Modulation (PM): Tactical Use in Small for Size (SFS) Live Donor Liver Transplantation (LDLT).
Objectives:Efforts to reduce the risk of donor hepatectomy have resulted in smaller grafts for transplantation. Grafts below 0.8% of recipient body weight (GW/RW), have been…2015 American Transplant Congress
Interventional Treatment With Minimal Surgery Is an Effective Way for Acute Portal Vein Thrombosis After Pediatric Liver Transplantation: The Experience of Largest Pediatric Liver Transplantation Center in China
Purpose: The purpose of this study was to evaluate the prognosis of interventional treatment through inferior mesenteric vein (IMV) and other treatments systemically for acute…2015 American Transplant Congress
Refinement of Non-Invasive Diagnostic Criteria to Differentiate Tumor from Bland Portal Vein Thrombosis Before Liver Transplant in Patients With Hepatocellular Carcinoma
University of California San Francisco, San Francisco, CA.
Differentiating tumor vs bland portal vein thrombosis (PVT) is essential in determining liver transplant (LT) candidacy for patients with hepatocellular carcinoma (HCC). The primary aim…
American Transplant Congress abstracts